More Realistic Comparable My apologies about reposting this but Forrestgump is obviously going out of his way to push everone else's post too the bottom of this board. Which means obviously he has some sort of agenda, once again for thos of you who want to see a more realistic comparable here you are.
More Realistic Comparable
Comparable CAN vs CBIS
Let's look at a closer comparables that I found in my DD process
Cannabis Science- (OTC: CBIS)
$68m MARKET
Cap (high of $220m!)
* NO platform technolgy
* NO Breeding & Culivation department
* Avg. mgmt team at best
* Share structure is abysmal...750m I/O!!
* Only two products in Pre-clinical!
Cannabis Technologies (C: CSE)
$14m Market Cap
* Valuable propietary Technology Platform
* Breeding & Cultivation Division
* Mgmt with track record of drug development to commercialization
* Excellent structure...36m I/O
* Product pipleine....not sure what's coming..but...has to be big based on credentailas of Dr. H!
Already have shown, Phase 1 Glaucoma Human Trials on 1st Therapy so this company truly is only still in its infancy.
GWPH did an IPO for $8.90 a share last May and the stock hit a high of $107 a share, obviously i'm not saying CAN is going there anytime soon but its not out of the realm of possibility within the next 3 to 5 years.
Read up on Dr.Sazzad's credentials, anything is possible...i'm sure people we're laughing at GWPH a few years ago and now look at them.